Russia’s COVID-19 Vaccine Generated an Immune Response, Study Shows
A COVID-19 vaccine in Russia produced neutralising antibodies in dozens of test subjects, according to a study published in the medical journal The Lancet.
The Tucson portion of Moderna's COVID-19 vaccine trail took an important step this week. Blood from participants is now being checked for antibodies, after they received both injections.
Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older people, as well as younger adults.
Credit: KTNV Channel 13 Las Vegas Duration: 00:21Published
Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,..
![Crucial next step in COVID-19 vaccine development taking place in Tucson [Video]](https://video.newsserve.net/300/v/20200930/2009302322-Crucial-next-step-in-COVID-19-vaccine-development.jpg)
![New promising results from Moderna vaccine trial [Video]](https://video.newsserve.net/300/v/20200930/2009301939-New-promising-results-from-Moderna-vaccine-trial.jpg)
![Moderna COVID-19 vaccine appears safe for older adults- study [Video]](https://video.newsserve.net/300/v/20200930/2009301606-Moderna-COVID-19-vaccine-appears-safe-for-older.jpg)
